ENBIO Balance Sheet Health
Financial Health criteria checks 6/6
ENBIO has a total shareholder equity of ₩43.8B and total debt of ₩16.4B, which brings its debt-to-equity ratio to 37.4%. Its total assets and total liabilities are ₩73.3B and ₩29.4B respectively.
Key information
37.4%
Debt to equity ratio
₩16.39b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩3.07b |
| Equity | ₩43.83b |
| Total liabilities | ₩29.43b |
| Total assets | ₩73.25b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A352940's short term assets (₩48.4B) exceed its short term liabilities (₩25.0B).
Long Term Liabilities: A352940's short term assets (₩48.4B) exceed its long term liabilities (₩4.5B).
Debt to Equity History and Analysis
Debt Level: A352940's net debt to equity ratio (30.4%) is considered satisfactory.
Reducing Debt: A352940's debt to equity ratio has reduced from 115.1% to 37.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A352940 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A352940 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 12.5% per year.